AstraZeneca PLC
AZN Healthcare Drug Manufacturers General
AstraZeneca PLC’s revenue for fiscal 2025 (year ended December 2025) was $58.7 billion, up 8.63% from fiscal 2024.
- Revenue
- +6.70%
- EPS
- +22.5%
- Free cash flow
- +1.99%
- Total debt
- +1.75%
Quarter to September 2026, against a year earlier
Follow AZN
Alert me
AstraZeneca PLC (AZN) Operating margin
AstraZeneca PLC's operating margin over the twelve months to 30 September 2026 was 23.7%, up 0.3 percentage points from fiscal 2025 (23.4%). Over the past ten years it has ranged from 2.82% (fiscal 2021) to 23.4% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers General industry median of 18.3% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 23.4% | 4.90 |
| FY2024 | 18.5% | 0.62 |
| FY2023 | 17.9% | 9.41 |
| FY2022 | 8.47% | 5.65 |
| FY2021 | 2.82% | (16.57) |
| FY2020 | 19.4% | 7.40 |
| FY2019 | 12.0% | (3.34) |
| FY2018 | 15.3% | (1.04) |
| FY2017 | 16.4% | (4.94) |
| FY2016 | 21.3% | 4.66 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 27.1% | 6.50 |
| Jun 2026 | 20.6% | (7.20) |
| Mar 2026 | 27.8% | 8.56 |
| Dec 2025 | 19.2% | (4.38) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| NVO Novo Nordisk A/S compare | 43.4% |
| AMGN Amgen Inc. compare | 32.4% |
| ABBV AbbVie Inc. compare | 32.2% |
| NVS Novartis AG compare | 25.2% |
| AZN AstraZeneca PLC | 23.7% |
| BMY Bristol Myers Squibb Company compare | 22.7% |
| PFE Pfizer Inc. compare | 21.4% |
| MRK Merck & Co., Inc. compare | 9.20% |
| GILD Gilead Sciences, Inc. compare | −7.63% |
| Drug Manufacturers General industry median | 18.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on AZN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement